IMMIX BIOPHARMA, INC. Debt Instrument, Interest Rate, Increase (Decrease)
IMMIX BIOPHARMA, INC. (IMMX) reported Debt Instrument, Interest Rate, Increase (Decrease) of 8.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:DebtInstrumentInterestRateIncreaseDecrease · last filed 2026-08-07
- IMMIX BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for the quarter ending 2026-03-31 was 8.00%, a 0.00% change year-over-year.
- IMMIX BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for the quarter ending 2025-03-31 was 8.00%, a 0.00% change year-over-year.
- IMMIX BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for the quarter ending 2024-03-31 was 8.00%.
- IMMIX BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for fiscal 2025 was 8.00%, a 0.00% change from fiscal 2024.
- IMMIX BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for fiscal 2024 was 8.00%.
| Period end | Debt Instrument, Interest Rate, Increase (Decrease) 3 month | Debt Instrument, Interest Rate, Increase (Decrease) 6 month | Debt Instrument, Interest Rate, Increase (Decrease) 9 month | Debt Instrument, Interest Rate, Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.00% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 8.00% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 8.00% 10-K/A · filed 2026-03-27 | |||
| 2025-09-30 | 8.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 8.00% 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | 8.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 8.00% 10-K · filed 2025-03-25 | |||
| 2024-09-30 | 8.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 8.00% 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | 8.00% 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |